104 related articles for article (PubMed ID: 7019784)
1. A national trial on the treatment of invasive bladder cancer.
Arnold EP; Bailey C; Burry AF; Bydder PV; Firth LA; Gowland S; Gray AJ; Mcllroy R
N Z Med J; 1981 Apr; 93(682):273-5. PubMed ID: 7019784
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials with hypoxic cell sensitizers-the European experience.
Dische S
Prog Clin Biol Res; 1983; 132D():293-303. PubMed ID: 6356146
[No Abstract] [Full Text] [Related]
3. Treatment of bladder carcinoma with irradiation combined with misonidazole.
Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
[TBL] [Abstract][Full Text] [Related]
5. Misonidazole in the clinic at Mount Vernon.
Dische S
Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials of misonidazole in the United States.
Wasserman TH; Stetz J; Phillips TL
Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
8. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
Abratt RP; Barnes DR; Hammond JA; Sarembok LA; Tucker RD; Williams AM
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of misonidazole combined with radiotherapy in the treatment of carcinoma of the esophagus--a double-blind randomized trial].
Irie G; Sakurai T; Kikuchi Y; Watari T; Ikeda M; Mochizuki S; Kamata R; Kaneda K; Mikuriya S; Sakura M
Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2085-92. PubMed ID: 6397547
[No Abstract] [Full Text] [Related]
10. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
Hoskin PJ; Saunders MI; Dische S
Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
[TBL] [Abstract][Full Text] [Related]
11. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
[No Abstract] [Full Text] [Related]
12. The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix.
Br J Radiol; 1984 Jun; 57(678):491-9. PubMed ID: 6372930
[TBL] [Abstract][Full Text] [Related]
13. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
Abratt RP
Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
[No Abstract] [Full Text] [Related]
14. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
Fazekas JT; Goodman RL; McLean CJ
Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912
[No Abstract] [Full Text] [Related]
15. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
Hampel N; Persky L
Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
[TBL] [Abstract][Full Text] [Related]
16. Combinations of radiation and misonidazole in a murine lung tumor model.
Siemann DW; Kochanski K
Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
[No Abstract] [Full Text] [Related]
17. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
[TBL] [Abstract][Full Text] [Related]
18. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
Awwad HK; Akhoush H; El-Merzabani M; El Badawy S; Barsoum M; el Baki HA
Radiother Oncol; 1984 Jun; 2(1):1-8. PubMed ID: 6095372
[TBL] [Abstract][Full Text] [Related]
19. A report on misonidazole in randomized trial in locally advanced head and neck cancer.
Sealy R; Williams A; Cridland S; Stratford M; Minchinton A; Hallet C
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):339-42. PubMed ID: 7050035
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of misonidazole in the curative treatment of infiltrating bladder cancer.
Bydder PV; Burry AF; Gowland S; Bourne RG; Chapman P; Firth LA; Gray AJ; McIlroy R
Australas Radiol; 1989 Feb; 33(1):8-14. PubMed ID: 2653300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
